Canada markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
269.87-9.73 (-3.48%)
At close: 03:34PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 18.35B
Enterprise Value 14.42B
Trailing P/E 29.66
Forward P/E 25.13
PEG Ratio (5 yr expected) 1.22
Price/Sales (ttm)7.84
Price/Book (mrq)4.02
Enterprise Value/Revenue 0.88
Enterprise Value/EBITDA 2.42

Trading Information

Stock Price History

Beta (5Y Monthly) 0.78
52-Week Change 3-32.26%
S&P500 52-Week Change 322.64%
52 Week High 3426.50
52 Week Low 3262.00
50-Day Moving Average 3292.12
200-Day Moving Average 3324.17

Share Statistics

Avg Vol (3 month) 31.02k
Avg Vol (10 day) 3910
Shares Outstanding 564.85M
Implied Shares Outstanding 667.99M
Float 864.67M
% Held by Insiders 10.01%
% Held by Institutions 148.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in DKK.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 26.42%
Operating Margin (ttm)35.70%

Management Effectiveness

Return on Assets (ttm)10.17%
Return on Equity (ttm)14.78%

Income Statement

Revenue (ttm)16.47B
Revenue Per Share (ttm)252.24
Quarterly Revenue Growth (yoy)-8.90%
Gross Profit (ttm)N/A
EBITDA 5.56B
Net Income Avi to Common (ttm)4.35B
Diluted EPS (ttm)9.09
Quarterly Earnings Growth (yoy)24.50%

Balance Sheet

Total Cash (mrq)28.14B
Total Cash Per Share (mrq)430.66
Total Debt (mrq)770M
Total Debt/Equity (mrq)2.44%
Current Ratio (mrq)13.34
Book Value Per Share (mrq)483.85

Cash Flow Statement

Operating Cash Flow (ttm)7.38B
Levered Free Cash Flow (ttm)5.29B